Select a medication above to begin.
Oseni
alogliptin/ pioglitazone
Black Box Warnings .
Congestive Heart Failure
thiazolidinediones cause or exacerbate CHF; observe pts closely after tx initiation or dose incr. for s/sx incl. excessive, rapid wt gain, dyspnea, and/or edema; manage CHF based on current care standards if s/sx develop and consider D/C or dose reduction; contraindicated in pts w/ NYHA Class III-IV CHF and not recommended in pts w/ symptomatic CHF
Adult Dosing .
Dosage forms: TAB: 12.5 mg/30 mg, 25 mg/15 mg, 25 mg/30 mg, 25 mg/45 mg
diabetes mellitus, type 2
- [25 mg/15 mg-25 mg/45 mg PO qd]
- Start: 25 mg/15 mg-25 mg/30 mg PO qd; Max: 25 mg/45 mg/day; Info: pts currently on pioglitazone may start at current daily pioglitazone dose; start 25 mg/15 mg PO qd in pts w/ NYHA Class I or II CHF; do not cut/crush/chew tab
renal dosing
- [see below]
- CrCl 30-59: 12.5 mg/30 mg qd; CrCl <30: avoid use, dose adjustment not possible w/ fixed-dose combo
- HD: avoid use, dose adjustment not possible w/ fixed-dose combo; PD: not defined
hepatic dosing
- [see below]
- Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: not defined
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.